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a b s t r a c t
Bioactive glasses (BG) which contain strontium have the potential to combine the known bone regen-
erative properties of BG with the anabolic and anti-catabolic effects of strontium cations. Here we
created a BG series (SiO2–P2O5–Na2O–CaO) in which 0–100% of the calciumwas substituted by strontium
and tested their effects on osteoblasts and osteoclasts in vitro. We show that ions released from
strontium-substituted BG enhance metabolic activity in osteoblasts. They also inhibit osteoclast activity
by both reducing tartrate resistant acid phosphatase activity and inhibiting resorption of calcium
phosphate ﬁlms in a dose-dependent manner. Additionally, osteoblasts cultured in contact with BG show
increased proliferation and alkaline phosphatase activity with increasing strontium substitution, while
osteoclasts adopt typical resorption morphologies. These results suggest that similarly to the osteopo-
rosis drug strontium ranelate, strontium-substituted BG may promote an anabolic effect on osteoblasts
and an anti-catabolic effect on osteoclasts. These effects, when combined with the advantages of BG such
as controlled ion release and delivery versatility, may make strontium-substituted BG an effective
biomaterial choice for a range of bone regeneration therapies.
 2010 Elsevier Ltd. All rights reserved.
1. Introduction
Osteoporosis is common among post-menopausalwomen and is
marked by an imbalance in the normal process of bone remodelling.
In osteoporotic bone, osteoclasts resorb too much bone while
osteoblasts fail to create enough, which together disrupt the bone
microarchitecture leaving it porous and prone to fracture. Annual
direct costs due to osteoporosis-related fracture in the United States
are estimated in the range of US$20 billion [1] and its disease burden
in Europe is estimated to be greater than that attributed to any
cancer save lung [2]. Strontium ranelate (SrR), sold under the trade
name Protelos, is a drug approved for the treatment and preven-
tion of osteoporosis and has been shown to reduce the number of
hip and vertebral fractures in post-menopausal women [3,4]. The
drug combines two atoms of stable strontium with the organic
moiety ranelic acid. The cellular mode of action of SrR appears to be
through the strontium cations themselves, which have been shown
to work both in vivo and in vitro by stimulating osteoblasts to make
new bone and preventing osteoclasts from resorbing bone [5,6].
That is, data suggest that SrR works by helping resident cells in the
bone to restore the normal bone remodelling balance.
Bioactive glasses (BG) form a strong bond with living tissue via
the formation of a hydroxyapatite layer on their surface [7] and
have been used to repair hard tissues in a variety of craniofacial,
maxillofacial, and periodontal applications [8]. BG particulate, for
example, is used in a variety of dental procedures [9], and many
BG compositions can be formed into scaffolds for tissue engi-
neering [10]. Surface reactivity, however, is not their only mech-
anism of action as BG also release ions that promote the osteoblast
phenotype [11,12]. In vitro studies have demonstrated that BG
stimulate osteoprogenitors to differentiate to mature osteoblasts
that produce bone-like nodules [13,14]. Similarly, in vivo studies
have shown gradual degradation of implanted BG with subse-
quent formation of new bone at the implant surface [15,16].
Because of similarities in their charge and ionic radius, strontium
can potentially be substituted for calcium in BG, creating a mate-
rial that may combine the bone bonding and osteoblast stimu-
lating properties of BG with the bone anabolic and anti-catabolic
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properties of SrR, and may act as an effective material for bone
regeneration applications.
Here we created a series of BG (SiO2–P2O5–Na2O–CaO) in
which strontium was substituted for calcium on a mole
percentage basis. We then tested their effects on cells cultured
both in contact with the BG and treated with culture media con-
taining ions released from the BG as they dissolved. The effects of
strontium substitution in the BG were tested on osteoblast and
osteoclast cultures and demonstrate that strontium-substituted
BG promote osteoblast proliferation and activity and decrease
osteoclast activity and resorption. As BG are a well-studied
biomaterial and excellent system for controlled ion release,
strontium-substituted BG may ﬁnd use in a range of bone regen-
eration applications including as porous scaffolds, rigid materials
and particulate.
2. Materials and methods
2.1. Bioactive glass synthesis
BG containing 46.46 SiO2 – 1.07 P2O5 – 26.38 Na2O – 23.08 (SrO:CaO) (mole %)
where either no calcium (0%) or 10, 50 or 100% of the calcium was substituted with
strontium were produced by a melt-quench route as previously described [17].
Brieﬂy, the compositionwas melted in a platinum crucible at 1400 C for 90 min and
rapidly quenched in deionised (dH2O) water. BG frits were then ground and sieved
to yield powders<38 mm in diameter. Some frits were also re-melted at 1450 C and
poured into pre-heated graphite moulds held just above the glass transition
temperature (which varied between 450 and 500 C depending on the percent
strontium substitution [17]) to obtain rods 10 mm in diameter. Discs 1 mm thick
were cut from the rods with a low speed diamond saw (Buehler IsoMet, Dusseldorf,
Germany) using isopropanol as a coolant.
2.2. Dissolution ion studies
2.2.1. Dissolution ion media
1.5 g/L of BG powder was added to RPMI 1640 or Dulbecco’s modiﬁed Eagle’s
(DMEM) cell culture medium (Invitrogen, Paisley, UK), incubated on a roller at 37 C
for 4 h and then passed through a 0.2 mm ﬁlter. Samples of dissolution ion media
were collected after 10, 30, 60, 120, and 240 min for elemental analysis. Media were
supplemented as described in Section 2.2.3 and equilibrated in a 37 C/5% CO2
incubator overnight before being placed on cells.
2.2.2. Elemental analysis
Cell culture media samples containing dissolution ions from BG were diluted by
a factor of 10 in dH2O and elemental concentrations of Ca, P, Si and Sr ions were
measured on an inductively coupled plasma – optical emission spectrometer (ICP-
OES) (iCAP 6000, Thermo Scientiﬁc, Waltham, MA, USA).
2.2.3. Cell culture with dissolution ions
The human osteosarcoma cell line, Saos-2, was obtained from the European
Collection of Cell Cultures (ECACC, Salisbury, UK) and routinely cultured under
standard conditions (37 C, 5% CO2/95% air, 100% humidity) in RPMI 1640 media
supplemented with 10% (v/v) foetal bovine serum (FBS) and 2 mM L-glutamine (all
reagents from Invitrogen). For experiments, cells were plated at 30,000 cells/cm2
and cultured for up to 28 days.
The mouse monocyte cell line, RAW264.7, which differentiates to osteoclasts
under appropriate conditions, was obtained from American Type Culture Collection
(ATCC, Teddington, UK) and cultured in DMEM containing 4.5 g/L glucose and 1.5 g/L
sodium bicarbonate (Sigma–Aldrich, Dorset, UK) supplemented with 10% (v/v) FBS
and 4 mM L-glutamine. The nitrogenous bisphosphonate pamidronate (Sigma),
a drug known to prevent osteoclast-mediated bone resorption in vivo [18], was
added at a concentration of 1 mM as a control. For erosion pit studies, an additional
control was created by adding 1 mM SrCl2$6H2O (Sigma) to standard cell culture
medium. To initiate differentiation, 20 ng/mL soluble murine Receptor Activator for
Nuclear Factor k B Ligand (RANKL, PeproTech EC, London, UK) was added. For
experiments, cells were plated at 30,000/cm2 (unless stated otherwise) and cultured
for up to 6 days.
2.2.4. Metabolic activity of cells
Cell metabolic activity was measured using the tetrazole MTT (3-(4,5-Dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Sigma), which is reduced to
formazan by mitochondria in metabolically active cells. 50 mL of a 5 mg/mL solution
of MTT in phosphate buffered saline (PBS) was added to the culture media of live
cells at indicated time points. After 2 h, media was removed and the formazan was
solubilised in dimethyl sulfoxide. The absorbance of the resulting solution was read
on a colorimetric plate reader at 592 nm.
2.2.5. Actin staining of cells
Differentiated RAW264.7 cultures were ﬁxed for 15 min in 4% (w/v) para-
formaldehyde in dH2O. After ﬁxation, cultures werewashed in PBS, permeabilised in
1% (v/v) Triton X-100 in dH2O for 5 min, washed again and then stained for 20 min
with AlexaFluor 568 Phalloidin (Invitrogen; 5 U/mL in 1% (w/v) bovine serum
albumin (BSA) in PBS) to visualise the actin cytoskeleton. Cultures were then rinsed
with 1% (w/v) BSA in PBS and DAPI was added to stain cell nuclei. Cultures were then
imaged using an epiﬂuorescent microscope.
2.2.6. Tartrate resistant acid phosphatase (TRAP) activity and total cell
quantiﬁcation
TRAP activity, a marker of osteoclast differentiation and resorbing activity [19],
was measured in RAW264.7 cells by quantifying the conversion of p-nitrophenyl
phosphate to p-nitrophenyl in the presence of sodium tartrate under acidic condi-
tions. After 2, 4, or 6 days in culture, cells were lysed in dH2O by three freeze-thaw
cycles and 1 mg/mL p-nitrophenyl phosphate in 0.1 M glycine buffer with 0.1 mM
ZnCl2, 0.1 mM MgCl2 and 20 mM sodium tartrate (pH ¼ 5.0) was added to the lysates.
The reaction was stopped with 1 M NaOH and the absorbance read at 405 nm on
a colorimetric plate reader. TRAP activity is expressed as nmoles p-nitrophenyl
liberated per minute. The total number of cells in the same lysates was determined
by quantifying the activity of the stable cytosolic enzyme lactate dehydrogenase
with a Cytotox96 Non-Radioactive Cytotoxicity Assay (Promega, Southampton,
UK), according to the manufacturer’s instructions.
2.2.7. Erosion pit formation by osteoclasts
The formation of erosion pits by differentiated RAW264.7 cells was evaluated
using BioCoat Osteologic (BD Biosciences Europe, Erembodegem, Belgium)
chamber well slides which are coated with a thin calcium phosphate (CaP) layer
suitable for cell culture. 9600 cells/well were cultured for 4 days in the presence of
20 ng/mL RANKL with either no additional supplements, 1 mM SrCl2$6H2O, 1 mM
pamidronate, or BG dissolution ion media. Cells were removed with sodium hypo-
chlorite and slides stained with silver nitrate according to the manufacturer’s
instructions. Micrographs of stained wells were taken on an inverted light micro-
scope and the eroded area was determined using the histogram function in ImageJ
(freeware from the NIH).
2.3. Bioactive glass discs studies
2.3.1. Cell culture on bioactive glass discs
BG discs were sterilised under UV light for 2 h per side and preconditioned for
three days in RPMI 1640 medium (exchanged every day). 30,000 Saos-2 cells/cm2
were seeded on BG discs and cultured for 1, 7, or 14 days in standard culture
medium, which was exchanged three times per week. 50,000 RAW264.7 mouse
monocytes/cm2 were also seeded on 0% strontium-substituted BG discs and differ-
entiated for 4 days in standard medium supplemented with 50 ng/mL RANKL to
visualise osteoclast differentiation.
2.3.2. Scanning electron microscopy (SEM) of osteoclasts
After 4 days, RAW264.7 cells on 0% strontium-substituted BG discs were
prepared for SEM imaging to view osteoclasts. Discs were washed twice in PBS
and ﬁxed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.3)
for 40 min at 4 C. Samples were then washed twice in PBS and dehydrated in
a graded ethanol series followed by critical point drying with hexamethylsilasane.
Following ﬁxation, discs were sputter coated with gold and viewed on a Leo 1525
Gemini SEM operated at 10 kV.
2.3.3. Alkaline phosphatase (ALP) activity and total cell quantiﬁcation
ALP activity, a marker of osteoblast differentiation and mineralisation, was
measured in Saos-2 cultured on BG discs using the substrate p-nitrophenyl
phosphate. At indicated time points, cultures were lysed in dH2O containing 0.9%
(v/v) Triton X-100 and reacted with 1 mg/mL p-nitrophenyl phosphate in 0.1 M
glycine buffer with 0.1 mM ZnCl2 and 0.1 mM MgCl2 (pH ¼ 10.4). The reaction was
stopped with 1 M NaOH and the absorbance read on a colorimetric plate reader at
405 nm. The total number of cells in the same lysates was determined using
a Cytotox96 Non-Radioactive Cytotoxicity Assay according to the manufacturer’s
instructions.
2.4. Statistical analyses
Statistical signiﬁcance in MTT, TRAP and ALP assays was assessed by ANOVA
with post-hoc LSD test to determine statistical signiﬁcance between individual
groups. A two-tailed Spearman’s r rank correlationwas used to determine statistical
signiﬁcance in erosion pit area experiments. A p value of less than 0.05 was
considered statistically signiﬁcant. For experiments on BG discs, n ¼ 6 per compo-
sition per time point. Erosion pit area data represent means of 2 experiments and
average data from at least 4 wells.
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3. Results
3.1. Bioactive glass formation
BG frits and rods were optically clear and were shown to be
amorphous by X-ray diffraction [17]. Solid state nuclear magnetic
resonance and vibrational spectroscopy further demonstrated that 0,
50 and 100%-strontium-strontium-substituted BG had predomi-
nantly Q2 silicate structures [17].
3.2. Dissolution ions studies
3.2.1. Ion release
The elemental concentrations of calcium, phosphorus, silicon
and strontium released from BG into cell culture media are shown
in Fig. 1. The dissolution of calcium into both RPMI 1640 and DMEM
was dependent on BG composition, with decreasing media calcium
concentration with increasing strontium substitution. The phos-
phorus concentration in RPMI 1640 changed little over the 4 h
release period while in DMEM a general decrease in phosphorus
concentration was observed for all BG compositions. The concen-
tration of silicon in both RPMI and DMEM increased with dissolu-
tion time and was variable depending on culture media type and
BG composition. The concentration of strontiumwas dependent on
BG compositionwith increasing strontium substitution resulting in
higher media strontium concentrations after 4 h.
3.2.2. Metabolic activity of cells
After 1 and 7 days in culture, therewere no signiﬁcant differences
in the MTT activity of Saos-2 cells treated with BG dissolution ions
compared to cells in standard culture medium (Fig. 2). After 14 and
28 days in culture, the MTT activity in cells treated with dissolution
ions from all compositions of BG was signiﬁcantly enhanced
compared to controls. After 14 days in culture, MTT activity was
signiﬁcantly greater in Saos-2 cells treated with dissolution ions
from 10, 50 and 100%-strontium-substituted BG compared to 0%-
strontiumsubstituted BG. After 28 days in culture, cells treated with
dissolution ions from 100% strontium-substituted BG had signiﬁ-
cantly higher MTT activity than that in any other group.
3.2.3. Formation of erosion pits by osteoclasts
RAW264.7 cells treated with RANKL formed erosion pits on CaP-
coated slides (Fig. 3a) while those treated with RANKL and 1 mM
pamidronate formed very few erosion pits (Fig. 3b). Mean erosion pit
area, an indicator of osteoclast activity, decreased when RAW264.7
monocytes were treated with dissolution ions from BG in which an
increasing proportion of calciumwas substituted for with strontium
(Fig. 3c). The correlation coefﬁcient between strontium substitution
and mean erosion pit area was r2 ¼ 0.94, which was statistically
signiﬁcant by Spearman’s rho rank correlation.
3.2.4. Osteoclast differentiation and TRAP activity
RAW264.7 cells differentiated to large multinucleated osteo-
clasts in the presence of RANKL. Actin staining highlighted typical
podosome belts in mature osteoclasts which appeared as prom-
inent rings encasing multiple nuclei (Fig. 4a). Cultures treated with
RANKL and 1 mM pamidronate (Fig. 4b) failed to form osteoclasts
with distinctive podosome belts. After 4 days in culture, cells
treated with dissolution ions from 100% strontium-substituted BG
showed signiﬁcantly less TRAP activity when compared to all other
BG treated groups (Fig. 4c). After 6 days in culture, RAW264.7
treated with dissolution ions from 10%, 50% and 100% strontium-
substituted BG all had signiﬁcantly lower TRAP activity when
compared to cells treated with dissolution ions from 0% strontium-
substituted BG. The presence of 1 mM pamidronate signiﬁcantly
reduced total TRAP activity at all time points compared to all other
groups. The presence of dissolution ions from all BG compositions,
however, did not have an effect on cell number as no signiﬁcant
differences were detected between any groups at any time point
(Fig. 4d). When TRAP activity was normalised to cell number,
similar trends were noted although ANOVA determined them not
be signiﬁcant with the exception that the group treated with 1 mM
pamidronate had signiﬁcantly lower TRAP activity per cell than any
other group at any time point (Supplementary Fig. 1).
3.3. Bioactive glass discs studies
3.3.1. Total cell quantiﬁcation
The total number of Saos-2 cells on BG discs increased over the
two-week culture period for all BG compositions (Fig. 5a). After 24 h
in culture, therewere no signiﬁcant differences between thenumber
of cells on any BG disc composition. However, after 7 days in culture,
there were signiﬁcantly more cells on 100%-strontium-substituted
BG discs than on 0%, and after 14 days in culture, there were signif-
icantly more cells on 50 and 100% strontium-substituted BG discs
compared to either 0 or 10% strontium-substituted BG discs.
3.3.2. ALP activity
Saos-2 cells cultured on BG discs showed increased total ALP
activity with increasing strontium substitution for calcium (Fig. 5b).
There were no signiﬁcant differences in total ALP per disc after 24 h
in culture, but after 1 week, cells on 100% strontium-substituted BG
discs had signiﬁcantly higher total ALP activity than those on 0% or
10% strontium-substituted BG discs. After 2 weeks in culture, cells
on BG discs with 50 or 100% strontium substitution had signiﬁ-
cantly higher total ALP activity than those on discs with 0% or 10%
strontium substitution. This trend held when ALP activity was
normalised per cell number as determined by LDH activity. There
were no signiﬁcant differences after 1 or 7 days in culture, but after
2 weeks, cells on BG discs containing 50 and 100% strontium
substitution had signiﬁcantly higher ALP activity per cell than those
on 0% strontium-substituted BG discs (Supplementary Fig. 2).
3.3.3. SEM of osteoclasts
RAW264.7 monocytes cultured on standard BG discs differen-
tiated to large cells with apico-basal polarisation, morphology
typical of resorbing osteoclasts (Fig. 6). Osteoclasts with similar
morphologies were observed adherent to the surfaces of all BG
compositions by SEM (not shown). Many undifferentiated mono-
cytes were also visible.
4. Discussion
Calcium has been reported to act as a network modiﬁer in sili-
cate glass systems such as BG. As strontium has a similar charge and
ionic radius to calcium, when it is substituted into the glass
network, it may play a similar role. The lower charge to size ratio of
the strontium ion compared to the calcium ion (due to the slighter
larger ionic radius of strontium), however, should create an
expanded and more loosely cross-linked glass network, but not
fundamentally alter the glass structure.
The release of calcium, phosphorus, silicon and strontium into
cell culture medium during incubation with BG is complicated by
ions already present in cell culture media, which themselves vary
among media formulations. Our ICP-OES data show that despite its
release from the BG, the calcium concentration in RPMI 1640
decreases and in DMEM stays fairly constant with incubation time.
This is likely due to the formation of a CaP layer on the surface of
the BG particles during incubation, which depletes the culture
media of calcium [20]. This hypothesis is supported by the decrease
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in phosphorus concentration over time during incubation of BG in
DMEM. The high concentration of phosphorus in RPMI 1640
(174 ppm) provides an excess available to form the CaP layer and so
its concentration does not signiﬁcantly diminish during incubation.
Silicon, which is thought to play a role in the cell-stimulating
activities of BG dissolution ions due its essential role in bone
formation [21], is released into culture media over time due to the
breakup of the outer silica layers of the BG network [10]. While
silicon release into simulated body ﬂuid is reported to happen
quickly (30 min–2 h), release into cell culture media proceeds more
slowly [20], and although our data show that the silicon
concentration in cell culture media increases with time for all BG
compositions and in both media formulations, it does not reach its
solubility limit (120 ppm in H20). As expected, the substitution of
strontium for calcium in BG results in increased levels of strontium
in both RPMI 1640 and DMEM cell culture media. Taken together,
these data suggest that the glass chemistry can be tailored to
release an appropriate level of strontium and/or other ions
depending on the application.
At early time points, the metabolic activity of Saos-2 cells
treated with BG dissolution ions was not signiﬁcantly different
from that observed in cells treated with standard culture medium
Fig. 1. Elemental concentrations of Ca, P, Si and Sr as determined by ICP-OES in cell culture media over 4 h incubation with BG particles in which 0, 10, 50 or 100% of the calciumwas
substituted for with strontium. Dissolution behaviour into (a) RPMI 1640 and (b) DMEM.
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indicating that the dissolution products of all compositions of BG
were non-cytotoxic. However, after 2 weeks in culture, dissolution
ions from all formulations of BG enhanced total metabolic activity
in Saos-2 cells compared controls. This has been previously shown
in primary human osteoblasts treated with 45S5 Bioglass dis-
solved in DMEM, which showed increased proliferation compared
to controls [22]. We also noted that MTT activity in cells treated
with strontium-substituted BG was signiﬁcantly enhanced
compared to non-strontium-containing groups. This suggests that
dissolution ions released from the strontium-substituted BG
further enhance metabolic activity in Saos-2 beyond that caused by
the presence of dissolution ions from standard BG. This is in
agreement with previous studies which have shown that SrR
promotes osteoblast proliferation [23] and suggests that strontium
ions may act synergistically with other ions (most likely silicon)
released from BG.
Treating RAW264.7 monocytes with dissolution ions from BG
with increasing strontium substitution reduced erosion pit area on
CaP-coated glass slides. This suggests that the strontium ions either
inhibit osteoclast differentiation or prevent mature osteoclasts
from eroding the coating. SrR has been previously shown to both
inhibit osteoclast differentiation and resorption activities in vitro
[24]. Recent studies have suggested that modulation of osteopro-
tegerin and RANKL expression, known regulators of osteoclast
activity and resorption, are responsible for this effect [25]. Others,
however, have shown that SrR inhibits osteoclast activity by pre-
venting the formation of the rufﬂed border region and clear zone
necessary for sealing and erosion pit formation [5,26]. Our data
show that dissolution ions from strontium-containing BG did not
prevent erosion pit formation to the same extent as the
bisphosphonate pamidronate. Bisphosphonates act by disrupting
the mevalonate pathway, disturbing osteoclast cytoskeleton
Fig. 2. Normalised MTT activity of Saos-2 human osteosarcoma cells treated with dissolution ions from standard BG and BG in which increasing proportions of calcium were
substituted for with strontium. Data represent mean þ standard deviation and are normalised to the mean value of controls after 1 day in culture. * indicates signiﬁcantly higher
MTT activity in the indicated group compared to the control group at the same time point. y compared to 0%, z compared to 10%, and x compared to 50% (all at the same time point).
Fig. 3. Representative images of erosion pits (bright) formed on calcium phosphate-coated chamber slides by RAW264.7 mouse monocytes cultured for 4 days in the presence of either
(a) RANKL alone or (b) RANKL combined with 1 mM pamidronate, a drug known to prevent osteoclast-mediated bone resorption in vivo. Scale bar in (a) and (b) is 1 mm. (c) Mean
erosion pit area (standard deviation) in calcium phosphate-coated chamber slides formed by RAW264.7 cells treated with RANKL and culture media containing dissolution ions from
standard and strontium-substituted BG (-). Cultures supplemented with RANKL alone (CNT B), 1 mM pamidronate (PAM B) and 1 mM SrCl2 (:) are shown for comparison.
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Fig. 4. (a) Representative epiﬂuorescense micrograph showing large multinucleated osteoclasts with typical podosome belts (arrows) in cultures of RAW264.7 mouse monocytes
after 4 days treatment with RANKL and dissolution ions from 50% strontium-substituted BG. (b) Epiﬂuorescense micrograph of RAW264.7 treated with RANKL and 1 mM
pamidronate in which no multinucleated osteoclasts are visible. Red ¼ phalloidin (actin), Blue ¼ DAPI (nuclei). Scale bar in (a) and (b) is 200 mm. (c) Total TRAP activity
(mean þ standard deviation) expressed as nmoles p-nitrophenyl liberated per minute in the presence of 20 mM tartrate in RAW264.7 differentiated in BG dissolution ion media or
with 1 mM pamidronate (PAM). All cultures were supplemented with 20 ng/mL RANKL. Pamidronate signiﬁcantly reduced total TRAP activity at all time points compared to all other
groups (#). After 4 days, RAW264.7 treated with 100% strontium-substituted BG had signiﬁcantly reduced TRAP activity compared to all other glass treated groups and controls
treated with RANKL alone (CNT) (*compared to CNT at same time point; y compared to 0%; z10%; x50%). After 6 days, cells treated with 10, 50 and 100% strontium-substituted BG
had signiﬁcantly lower TRAP activity when compared to 0% (y). (d) Total number of cells in cultures of RAW264.7 monocytes treated with dissolution ions from BG or pamidronate.
There were no signiﬁcant differences between the number of cells detected in any group.
E. Gentleman et al. / Biomaterials 31 (2010) 3949–39563954
formation and their ability to form a rufﬂed border region
(reviewed in [27]). The mechanism by which strontium ions
prevent erosion pit formation in the present study is not clear, but
inhibition of differentiation and disruption of cytoskeletal elements
are two possibilities.
Substituting strontium for calcium in BG signiﬁcantly decreased
TRAP activity in cultures treatedwith their dissolution ions. ICP-OES
demonstrated that DMEM cell culture medium treated with 100%-
strontium-substituted BG had a strontium concentration of 84 ppm
which is similar to the concentration of strontium in cultures sup-
plemented with 1 mM Sr2þ (88 ppm) (as either SrCl2$6H2O or SrR),
which has also been shown to prevent osteoclast-mediated erosion
of dentine slices [26] and apatite-coated matrices [5]. This level,
however, is still higher than that in the serum of patients treated
with SrR (0.12 mM Sr2þ or w10 ppm [3]). Decreased TRAP activity,
however, did not come as a result of cell death. While there is
evidence of an apoptotic effect of SrR on osteoclasts [28,29], we
could not detect signiﬁcant differences in the number of cells in
different groups at any time point. This is in agreement with studies
which have shown that SrR does not affect attachment to or viability
of osteoclasts on bone slices, but does reduce osteoclast differenti-
ation and resorption activity [24]. Hurtel-Lemaire et al. have shown
that SrR does induce osteoclast apoptosis, however, this was only
evident at Sr2þ concentrations of 9 mM and higher, far more than
that tested here andmore than order of magnitude higher than that
present in the serum of patients treated with SrR [29].
No addition of strontium to cell culturemedia by dissolution ions
from BG reduced TRAP activity to the same extent as pamidronate.
This is in keeping with results from a recent clinical trial that
demonstrated a more subtle bone remodelling effect of SrR as
compared to other osteoporosis treatments [30]. Parathyroid
hormone (PTH) treatment enhances bone mineral density by both
increasing bone formation and resorption. Anti-catabolic agents
such as bisphosphonates, on the other hand, inhibit bone turnover,
preserving the existing skeletal microarchitecture. Because of its
mode of action, there has been concern that long-term treatment
with bisphosphonates may ‘freeze’ bone, prohibiting normal repair
processes. Recent reports of osteonecrosis in the jaw of patients
treated with bisphosphonates seem to conﬁrm this [31]. Neither
PTHnor bisphosphonate treatments, however, address the lost bone
remodelling balance inherent to osteoporosis. Bone regeneration
therapies involving strontium may be preferred in this regard as
they prevent osteoclast resorption without diminishing bone min-
eralisation and formation.
Strontium-substituted BG not only stimulated increased osteo-
blast metabolic activity and inhibited osteoclast differentiation and
resorption via their dissolution ions, but also promoted osteoblast
proliferation and ALP activity while directly in contact with cells.
This is in agreement with studies on standard BG which have been
shown to stimulate the expression of a number of osteogenic genes
(reviewed in [32]), although themechanism bywhich ions released
from BG act on cells remains unclear. There is evidence that
strontium’s effect is mediated by cation-sensing receptors other
than the calcium-sensing receptor (CaSR) [33,34]. This is supported
by data demonstrating that neither calcium nor sodium ranelate
had the same effects as their strontium counterpart [23,26].
However, this has been refuted by other studies which have
demonstrated that strontium’s effect is CaSR dependent [25,29],
although an effect mediated by a combination of receptors cannot
be ruled out.
Osteoclasts on BG discs assumed typical resorption morphol-
ogies, which was in contrast to non-resorbing morphologies noted
in osteoclasts on tissue culture plastic. Previous studies have
demonstrated that only when adherent to apatite do osteoclasts
assume typical apico-basal polarisation and form sealing rings [35]
suggesting that the BG discs examined in this study are sufﬁcient to
elicit a normal bone remodelling response. Our data also suggest
that ions dissolved from BG are not sufﬁcient on their own to
Fig. 5. (a) Total number of cells on BG discs after 1, 7 and 14 days in culture as
determined by measuring lactate dehydrogenase activity. After 7 days in culture, there
were signiﬁcantly more cells on 100%-strontium-substituted BG discs than on 0%, and
after 14 days in culture there were signiﬁcantly more cells on 50 and 100% strontium-
substituted BG discs compared to either 0 or 10% (y signiﬁcantly more cells compared
to 0% at the same time point, z compared to 10%). (b) Total alkaline phosphatase (ALP)
activity (mean þ standard deviation) in Saos-2 cells on 0% strontium-substituted BG
discs and BG inwhich 10, 50 or 100% of the calciumwas substituted for with strontium.
After 7 days in culture, cells on 100% strontium-substituted BG discs had signiﬁcantly
higher total ALP activity than those on 0% or 10%-strontium-substituted BG discs. After
2 weeks in culture, cells on discs in which 50 or 100% of the calcium had been
substituted for with strontium had signiﬁcantly higher total ALP activity than those on
0% or 10% strontium-substituted BG discs (y signiﬁcantly greater total ALP activity
compared to 0% at the same time point, z compared to 10%).
Fig. 6. SEM image of osteoclast on 0% strontium-substituted BG disc after 4 days in
culture. A large osteoclast with a typical apico-basal polarised resorbing morphology
(black arrow) is visible as are many undifferentiated monocytes (white arrows). Scale
bar is 100 mm.
E. Gentleman et al. / Biomaterials 31 (2010) 3949–3956 3955
promote a resorption phenotype as osteoclasts cultured on tissue
culture plastic in the presence of BG dissolution ions maintained
ﬂattened non-resorbing morphologies. This is in agreement with
previous studies which have shown that microenvironmental cues
alone do not trigger osteoclast polarisation and sealing zone
formation [35].
5. Conclusions
Strontium can be substituted for calcium in BG, creating
a biomaterial that increases osteoblast proliferation and ALP activity,
and inhibits TRAP activity and osteoclast-mediated resorption of CaP
ﬁlms, in a similar manner to the osteoporosis drug SrR. As BG are
a well-studied biomaterial system capable of controlled ion release
and are deliverable as particulate, scaffolds or bulk material, substi-
tution of strontium for calcium in BGmay be an effective strategy for
creating materials for bone repair/regeneration therapies.
Acknowledgements
The authors wish to thank Dr. Morgan Mager for assistance with
image processing, Ms. Sabrina Skeete for laboratory assistance and
Mr. Nick Walters for help with ICP-OES. The authors acknowledge
funding from the UK Department of Trade and Industry (now the
Technology Strategy Board).
Appendix
Figures with essential colour discrimination. Part of Fig. 4 of this
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images can be found in the online version, at doi:10.1016/j.
biomaterials.2010.01.121.
Appendix. Supplementary information
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.biomaterials.2010.01.121.
References
[1] Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Inci-
dence and economic burden of osteoporosis-related fractures in the United
States, 2005–2025. J Bone Miner Res 2007;22(3):465–75.
[2] Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability
associated with osteoporotic fractures. Osteoporos Int 2006;17(12):1726–33.
[3] Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al. The
effects of strontium ranelate on the risk of vertebral fracture in women with
postmenopausal osteoporosis. N Engl J Med 2004;350(5):459–68.
[4] Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, et al.
Effects of long-term strontium ranelate treatment on the risk of nonvertebral
and vertebral fractures in postmenopausal osteoporosis: results of a ﬁve-year,
randomized, placebo-controlled trial. Arthritis Rheum 2008;58(6):1687–95.
[5] Bonnelye E, Chabadel A, Saltel F, Jurdic P. Dual effect of strontium ranelate:
stimulation of osteoblast differentiation and inhibition of osteoclast formation
and resorption in vitro. Bone 2008;42(1):129–38.
[6] Marie PJ, Hott M, Modrowski D, Depollak C, Guillemain J, Deloffre P, et al. An
uncoupling agent containing strontium prevents bone loss by depressing
bone-resorption and maintaining bone-formation in estrogen-deﬁcient rats.
J Bone Miner Res 1993;8(5):607–15.
[7] Hench LL, Splinter RJ, Allen WC, Greenlee Jr TK. Bonding mechanisms at the
interface of ceramic prosthetic materials. J Biomed Mater Res 1971;2(1):
117–41.
[8] Hench LL. Bioceramics – from concept to clinic. J Am Ceram Soc 1991;74(7):
1487–510.
[9] Shapoff CA, Alexander DC, Clark AE. Clinical use of a bioactive glass particulate
in the treatment of human osseous defects. Compend Contin Educ Dent
1997;18(4):352–4. 6, 8 passim.
[10] Jones JR, Gentleman E, Polak J. Bioactive glass scaffolds for bone regeneration.
Elements 2007;3(6):393–9.
[11] Effah Kaufmann EA, Ducheyne P, Shapiro IM. Evaluation of osteoblast response
to porous bioactive glass (45S5) substrates by RT-PCR analysis. Tissue Eng
2000;6(1):19–28.
[12] Jell G, Notingher I, Tsigkou O, Notingher P, Polak JM, Hench LL, et al. Bioactive
glass-induced osteoblast differentiation: a noninvasive spectroscopic study.
J Biomed Mater Res A 2008;86(1):31–40.
[13] Tsigkou O, Hench LL, Boccaccini AR, Polak JM, Stevens MM. Enhanced differ-
entiation and mineralization of human fetal osteoblasts on PDLLA containing
bioglass composite ﬁlms in the absence of osteogenic supplements. J Biomed
Mater Res A 2007;80(4):837–51.
[14] Tsigkou O, Jones JR, Polak JM, Stevens MM. Differentiation of fetal osteoblasts
and formation of mineralized bone nodules by 45S5 bioglass conditioned
medium in the absence of osteogenic supplements. Biomaterials 2009;30(21):
3542–50.
[15] Merolli A, Leali PT, Guidi PL, Gabbi C. Comparison in in-vivo response between
a bioactive glass and a non-bioactive glass. J Mater Sci Mater Med
2000;11(4):219–22.
[16] Gil-Albarova J, Salinas AJ, Bueno-Lozano AL, Roman J, Aldini-Nicolo N, Garcia-
Barea A, et al. The in vivo behaviour of a sol-gel glass and a glass-ceramic
during critical diaphyseal bone defects healing. Biomaterials
2005;26(21):4374–82.
[17] FredholmY, StevensMM,Hill R. Inﬂuence of strontium substitution of calciumon
bioactive glass physical properties. In: Proceedings of the 8thWorld Biomaterials
Congress, 28 May–1 June 2008, Amsterdam RAI, the Netherlands; 2008.
[18] Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and
long-term oral bisphosphonate therapy. N Engl J Med 2009;360(1):53–62.
[19] Kirstein B, Chambers TJ, Fuller K. Secretion of tartrate-resistant acid phos-
phatase by osteoclasts correlates with resorptive behavior. J Cell Biochem
2006;98(5):1085–94.
[20] Sepulveda P, Jones JR, Hench LL. In vitro dissolution of melt-derived 45S5 and
sol-gel derived 58S bioactive glasses. J Biomed Mater Res 2002;61(2):301–11.
[21] Carlisle EM. Silicon: an essential element for the chick. Science 1972;178(61):
619–21.
[22] Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive
glass dissolution increase proliferation of human osteoblasts and induce
insulin-like growth factor II mRNA expression and protein synthesis. Biochem
Biophys Res Commun 2000;276(2):461–5.
[23] Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt
S12911 enhances bone cell replication and bone formation in vitro. Bone
1996;18(6):517–23.
[24] Baron R, Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and
bone marrow macrophage differentiation. Eur J Pharmacol 2002;450(1):11–7.
[25] Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, Mason RS. Osteo-
blasts play key roles in the mechanisms of action of strontium ranelate. Br J
Pharmacol 2009;157(7):1291–300.
[26] Takahashi N, Sasaki T, Tsouderos Y, Suda TS. 12911-2 inhibits osteoclastic bone
resorption in vitro. J Bone Miner Res 2003;18(6):1082–7.
[27] Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics
2007;119(Suppl. 2):S150–62.
[28] Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S, et al. The
calcium sensing receptor is directly involved in both osteoclast differentiation
and apoptosis. FASEB J 2006;20:2562–4.
[29] Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S,
et al. The calcium-sensing receptor is involved in strontium ranelate-induced
osteoclast apoptosis. New insights into the associated signaling pathways.
J Biol Chem 2009;284(1):575–84.
[30] Recker RR, Marin F, Ish-Shalom S, Moricke R, Hawkins F, Kapetanos G, et al.
Comparative effects of teriparatide and strontium ranelate on bone biopsies
and biochemical markers of bone turnover in postmenopausal women with
osteoporosis. J Bone Miner Res 2009;24(8):1358–68.
[31] Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates.
N Engl J Med 2005;353(1):99–102.
[32] Jell G, Stevens MM. Gene activation by bioactive glasses. J Mater Sci Mater Med
2006;17(11):997–1002.
[33] Pi M, Quarles LD. A novel cation-sensing mechanism in osteoblasts is
a molecular target for strontium. J Bone Miner Res 2004;19(5):862–9.
[34] Fromigue O, Hay E, Barbara A, Petrel C, Traiffort E, Ruat M, et al. Calcium
sensing receptor-dependent and receptor-independent activation of osteo-
blast replication and survival by strontium ranelate. J Cell Mol Med
2009;13(8B):2189–99.
[35] Saltel F, Destaing O, Bard F, Eichert D, Jurdic P. Apatite-mediated actin
dynamics in resorbing osteoclasts. Mol Biol Cell 2004;15(12):5231–41.
E. Gentleman et al. / Biomaterials 31 (2010) 3949–39563956
